Tag: drug safety

Future Trends: AI, Automation and Real-World Data in Safety Reconciliation with EDC/Source Future Trends: AI, Automation and Real-World Data in Safety Reconciliation with EDC/Source Introduction to Safety Reconciliation in Clinical Trials The safety reconciliation process is an integral component of clinical trials, particularly concerning clinical research services. It ensures that all adverse events (AEs) reported…

Read More “Future Trends: AI, Automation and Real-World Data in Safety Reconciliation with EDC/Source” »

Integrating Safety Reconciliation with EDC/Source With DSURs, PBRERs and Risk Management Plans Integrating Safety Reconciliation with EDC/Source With DSURs, PBRERs and Risk Management Plans Introduction to Safety Reconciliation in Clinical Trials In the realm of world wide clinical trials, integrating safety reconciliation with Electronic Data Capture (EDC) systems and source documents is essential for ensuring…

Read More “Integrating Safety Reconciliation with EDC/Source With DSURs, PBRERs and Risk Management Plans” »

Integrating Safety Reconciliation with EDC/Source With DSURs, PBRERs and Risk Management Plans As clinical trials become increasingly complex, the integration of safety reconciliation processes with Electronic Data Capture (EDC) systems and source documents becomes critical. This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals. It focuses on aligning…

Read More “Integrating Safety Reconciliation with EDC/Source With DSURs, PBRERs and Risk Management Plans” »

Vendor and Partner Oversight Considerations in Safety Reconciliation with EDC/Source Vendor and Partner Oversight Considerations in Safety Reconciliation with EDC/Source In the domain of clinical trials, effective oversight of vendors and partners during safety reconciliation is indispensable for ensuring compliance with regulatory standards and safeguarding participant safety. This step-by-step tutorial aims to provide a comprehensive…

Read More “Vendor and Partner Oversight Considerations in Safety Reconciliation with EDC/Source” »

Vendor and Partner Oversight Considerations in Safety Reconciliation with EDC/Source Vendor and Partner Oversight Considerations in Safety Reconciliation with EDC/Source Introduction to Safety Reconciliation in Clinical Trials In the domain of clinical trials, ensuring the safety of participants is paramount. Safety reconciliation involves the systematic verification and comparison of data related to adverse events (AEs)…

Read More “Vendor and Partner Oversight Considerations in Safety Reconciliation with EDC/Source” »

Training Investigators and Sites to Execute Safety Reconciliation with EDC/Source Reliably The execution of safety reconciliation in clinical trials using Electronic Data Capture (EDC) systems and source documents is essential for ensuring the integrity and accuracy of adverse event (AE) reports. This tutorial serves as a comprehensive guide for clinical operations, regulatory affairs, and medical…

Read More “Training Investigators and Sites to Execute Safety Reconciliation with EDC/Source Reliably” »

Inspection-Ready Documentation Standards for Safety Reconciliation with EDC/Source Inspection-Ready Documentation Standards for Safety Reconciliation with EDC/Source In the realm of clinical trials, particularly in studies involving products like donanemab, it is paramount to maintain inspection-ready documentation standards throughout the trial lifecycle. This ensures compliance with regulatory requirements from entities such as the FDA in the…

Read More “Inspection-Ready Documentation Standards for Safety Reconciliation with EDC/Source” »

KRIs, KPIs and Dashboards to Monitor Safety Reconciliation with EDC/Source Across Portfolios KRIs, KPIs and Dashboards to Monitor Safety Reconciliation with EDC/Source Across Portfolios The monitoring and management of safety in clinical trials is a critical aspect of research and regulatory compliance in the pharmaceutical and biopharmaceutical industries. Key Risk Indicators (KRIs), Key Performance Indicators…

Read More “KRIs, KPIs and Dashboards to Monitor Safety Reconciliation with EDC/Source Across Portfolios” »

Case Studies: Safety Reconciliation with EDC/Source That Strengthened Safety Oversight Case Studies: Safety Reconciliation with EDC/Source That Strengthened Safety Oversight Introduction to Safety Reconciliation in Clinical Trials In the realm of clinical trials, particularly within the framework of the clinical trial center, safety reconciliation has become a critical aspect of ensuring patient safety and data…

Read More “Case Studies: Safety Reconciliation with EDC/Source That Strengthened Safety Oversight” »

Common Pitfalls in Safety Reconciliation with EDC/Source—and How to Avoid Regulatory Findings In clinical research, the safety of trial participants is paramount. As biosimilar clinical trials expand, safety reconciliation between Electronic Data Capture (EDC) systems and source documents becomes increasingly complex. This guide aims to provide clinical operations, regulatory affairs, and medical affairs professionals with…

Read More “Common Pitfalls in Safety Reconciliation with EDC/Source—and How to Avoid Regulatory Findings” »